OGN

Organon & Co. · Healthcare · Drug Manufacturers - General
$13.76
+0.00 (+0.00%)
Mkt Cap: 3.61B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield28.9%
Dividend YieldN/A
Market Cap3.61B
Volume2.71M
Recent News
Bank of America Corp DE Has $4.42 Million Stock Position in Organon & Co. $OGN
defenseworld.net · 2026-08-29
National Can-RISE Study to Help Close Critical Gaps in Menopause Research
globenewswire.com · 2026-08-27
Organon & Co. (NYSE:OGN) Sets New 52-Week High – Still a Buy?
defenseworld.net · 2026-08-25
Orogen Royalties Acquires a Royalty on the Haldane Silver Project
accessnewswire.com · 2026-08-20
Orogen Royalties and Aurum Discovery form Generative Alliance in Norway
accessnewswire.com · 2026-08-17
Organon & Co. $OGN Shares Purchased by California State Teachers Retirement System
defenseworld.net · 2026-08-12

Unlock the Full Deep Scan

9 AI agents analyze OGN across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →